跳至主要内容
临床试验/EUCTR2004-002051-13-GB
EUCTR2004-002051-13-GB进行中(未招募)不适用

A randomised double-blind placebo-controlled trial of oral misoprostol for cervical priming before outpatient hysteroscopy

Imperial College, London0 个研究点目标入组 200 人开始时间: 2005年7月21日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • All women attending outpatient hysteroscopy clinic.
  • Patients who ahve given written consent for participation.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Pregnancy, Patients with endometrial thickness of less than 4mm on ultrasound scan as they do not require a hysteroscopy, Contraindications of hysteroscopy, Contraindications to prostaglandins (patients where an episode of hypotension may be precipitate problems; cardiovascular, cerebrovascular disease and peripheral vascular disease), Patients already taking misoprostol or ArthrotecË (contains 200ºg misoprostol), Cervical abnormalities (false passage, space occupying lesion in cervical canal), Presence of significant uterovaginal prolapse and Failure to obtain informed consent.

研究者

相似试验

A randomised double-blind placebo-controlled trial... | 临床试验